Welcome to our dedicated page for TransUnion SEC filings (Ticker: TRU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The TransUnion (NYSE: TRU) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents offer detailed information on TransUnion’s financial performance, governance and significant corporate events, complementing its role as a global information and insights company and major U.S. credit bureau.
Investors can review current reports on Form 8-K, where TransUnion reports material events such as quarterly earnings announcements and board changes. For example, the company has used 8-K filings to furnish press releases on results for specific quarters and to disclose the appointment of new directors and committee assignments. Such filings help readers understand how TransUnion’s leadership and reporting practices evolve over time.
In addition to 8-Ks, users typically look to annual reports on Form 10-K and quarterly reports on Form 10-Q for comprehensive discussions of business segments, risk factors, credit and fraud solution portfolios, and geographic footprint. These filings explain how TransUnion’s core credit bureau activities, fraud and identity solutions, marketing datasets and analytics offerings contribute to its overall business.
The Stock Titan platform enhances this information by providing AI-powered summaries that highlight key points from lengthy filings, helping readers navigate complex disclosures more efficiently. Real-time updates from the SEC’s EDGAR system ensure that new TransUnion filings appear promptly, while dedicated sections for insider transaction reports on Form 4 and proxy materials give additional insight into executive and director activity and governance matters.
Together, these resources allow investors, analysts and other stakeholders to examine TransUnion’s regulatory history, financial reporting and material events in a structured, accessible format.
TransUnion director reports no beneficial ownership on Form 3
TransUnion director Sayan Chakraborty filed an initial ownership report stating that no TransUnion securities are beneficially owned. The filing confirms Chakraborty’s role as a director and indicates that there are no non-derivative or derivative securities reported as directly or indirectly held. This is an administrative disclosure required for insiders and does not describe any stock transactions or option grants.
TransUnion's President, International reported a small insider stock sale under a pre-arranged Rule 10b5-1 trading plan. On 01/02/2026, the officer sold 500 shares of TransUnion common stock at a price of $85.71 per share. After this transaction, the officer beneficially owns 32,224.727 shares of common stock. This ownership amount includes 72.708 shares acquired through the company’s employee stock purchase plan since the officer’s prior report.
TransUnion reported an insider stock sale by a senior officer. On 01/02/2026, an officer serving as President, US Markets sold 1,000 shares of TransUnion common stock at a price of $85.71 per share in an open market transaction.
The filing states that this sale was made under a pre-arranged Rule 10b5-1 trading plan, which is designed to allow insiders to trade shares according to a set schedule. After this transaction, the officer beneficially owned 61,592 shares of TransUnion common stock.
A shareholder of TransUnion filed a notice to sell 500 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $42,855.00. The shares to be sold come from 413 shares acquired through restricted stock vesting on 02/25/2025 as compensation and 87 shares purchased under an employee stock purchase plan on 06/30/2025 for cash. Over the prior three months, the same shareholder, Todd Skinner, sold 500 common shares on 12/10/2025 for gross proceeds of $40,535.00. By signing the notice, the shareholder represents that he is not aware of any undisclosed material adverse information about TransUnion.
TRU insider Steven Chaouki has filed a notice of proposed sale of 1,000 common shares through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $85,710.00. The filing states that there were 194,200,000 common shares outstanding at the time of the notice.
The shares to be sold were acquired on 02/20/2022 through restricted stock vesting from the issuer as compensation. Over the past three months, Chaouki has already sold 2,000 common shares in two transactions, generating gross proceeds of $80,470.00 on 11/03/2025 and $84,040.00 on 12/01/2025. By signing, the seller represents not knowing any undisclosed material adverse information about the issuer.
TransUnion reported changes to its Board of Directors. On December 19, 2025, the Board voted to increase its size from 10 to 12 members, effective January 5, 2026. On the same date, Sayan Chakraborty and Charlotte B. Yarkoni were appointed as new directors, effective January 5, 2026, to fill the two newly created seats.
Both new directors will serve until the 2026 annual meeting of stockholders and until their successors are elected and qualified. Mr. Chakraborty will join the Technology Committee, while Ms. Yarkoni will serve on the Compensation Committee, each effective January 5, 2026. They will be compensated under TransUnion’s standard policies for non-employee independent directors, and the company states there are no related-party arrangements or transactions requiring additional disclosure.
TransUnion's Executive Vice President and Chief Operations Officer reported a planned sale of company stock. On 12/17/2025, the officer sold 4,318 shares of TransUnion common stock at $86 per share in an open-market transaction coded as a sale. The filing notes that the trades were executed under a pre-arranged Rule 10b5-1 trading plan, which is designed to allow insiders to sell shares according to a predetermined schedule. Following this transaction, the officer directly owns 50,427 shares of TransUnion common stock.
A holder of the issuer’s common stock filed a notice under Rule 144 to sell 4,318 shares through Fidelity Brokerage Services LLC. The planned sale has an aggregate market value of $371,348.00 and is expected around 12/17/2025 on the NYSE. According to the notice, 194,200,000 shares of the issuer’s common stock were outstanding. The securities to be sold were acquired as restricted stock that vested on 09/03/2025 as compensation from the issuer.
TransUnion's President, International reported a small planned stock sale. On 12/10/2025, the executive sold 500 shares of TransUnion common stock at $81.07 per share under a pre-arranged Rule 10b5-1 trading plan.
After this transaction, the officer directly beneficially owned about 32,652 shares of TransUnion common stock. The filing is a routine ownership report showing a modest disposition by a senior executive made pursuant to an established trading plan.
TransUnion has a shareholder planning to sell 500 shares of its common stock under Rule 144. The shares are to be sold through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $40,535 at the time indicated in the notice. The shares were acquired on 02/25/2025 through restricted stock vesting as compensation from the issuer. The notice also reports that there are 194,200,000 common shares outstanding, which serves as a baseline for understanding the small size of this planned sale relative to the total equity.